APA (7th ed.) Citation

C, L., J, B., R, D. d. V., SS, E., E, N., J, P., . . . AM, L. (2025). The Composite Number Needed to Treat for Semaglutide in Populations with Overweight or Obesity and Established Cardiovascular Disease Without Diabetes. Advances in therapy, 42(5), 2513. https://doi.org/10.1007/s12325-025-03176-w

Chicago Style (17th ed.) Citation

C, Lübker, Bhavsar J, Duque do Vale R, Emerson SS, Nørtoft E, Plutzky J, Roberts G, Tarp JM, and Lincoff AM. "The Composite Number Needed to Treat for Semaglutide in Populations with Overweight or Obesity and Established Cardiovascular Disease Without Diabetes." Advances in Therapy 42, no. 5 (2025): 2513. https://doi.org/10.1007/s12325-025-03176-w.

MLA (9th ed.) Citation

C, Lübker, et al. "The Composite Number Needed to Treat for Semaglutide in Populations with Overweight or Obesity and Established Cardiovascular Disease Without Diabetes." Advances in Therapy, vol. 42, no. 5, 2025, p. 2513, https://doi.org/10.1007/s12325-025-03176-w.